Antihyperalgesic activity of verbascoside in two models of neuropathic pain

Journal of Pharmacy and Pharmacology

Volumn 63, Issue 4, 2011, Pages 594-601

  Isacchi, Benedetta ^a   Iacopi, Romina ^a   Bergonzi, Maria Camilla ^a   Ghelardini, Carla ^a   Galeotti, Nicoletta ^a   Norcini, Monica ^a   Vivoli, Elisa ^a   Vincieri, Franco Francesco ^a   Bilia, Anna Rita ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Antihyperalgesic; Lippia citriodora; Neuropathic pain; Paw pressure test; Verbascoside

Indexed keywords

ACTEOSIDE; IODOACETIC ACID; KETOROLAC; MORPHINE; PREGABALIN; TRAMADOL;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMATOGRAPHY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG STRUCTURE; HYPERALGESIA; LIPPIA; LIPPIA CITRIODORA; MONONEUROPATHY; NERVE COMPRESSION; NERVE INJURY; NEUROPATHIC PAIN; NONHUMAN; RAT; SCIATIC NERVE;

ADMINISTRATION, ORAL; ANALGESICS; ANIMALS; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; GLUCOSIDES; HYPERALGESIA; INJECTIONS, INTRAPERITONEAL; IODOACETATES; LIPPIA; MALE; NEURALGIA; PHENOLS; PHYTOTHERAPY; RATS; RATS, SPRAGUE-DAWLEY; ROTAROD PERFORMANCE TEST; SCIATIC NERVE;

EID: 79952731093     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2011.01264.x     Document Type: Article

References (24)

1. Scogin R. The distribution of acteoside among angiosperms. Biochem Syst Ecol 1997; 20: 477-480.
2. Küpeli E et al. In vivo anti-inflammatory and antinociceptive activity evaluation of phenolic compounds from Sideritis stricta. Naturforsch [C] 2007; 62: 519-525. (Pubitemid 47407714)
3. Jiangshu Botanic Institute, Institute of Materia Medica CAMS, Kunming Botanic Institute. Xinhua Bencao Gangyao II. Shanghai: Scientific and Technical Press, 1991.
4. 2+] and nitric oxide/ cyclic GMP pathway. Life Sci 2004; 75: 1149-1157.
5. Korkina LG et al. Molecular mechanisms underlying wound healing and anti-inflammatory properties of naturally occurring biotecnologically produced phenylpropanoid glycosides. Cell Mol Biol 2007; 30: 84-91. (Pubitemid 350164309)
6. Hausmann M et al. In vivo treatment with herbal phenylethanoid acteoside ameliorates intestinal inflammation in dextran sulphate sodium-induced colitis. Clin Exp Immunol 2007; 148: 373-381. (Pubitemid 46587594)
7. Fleer H, Verspohl EJ. Antispasmodic activity of an extract from Plantago lanceolata L. and some isolated compounds. Phytomedicine 2007; 14: 409-415. (Pubitemid 46818008)
8. Penido C et al. Anti-inflammatory and anti-ulcerogenic properties of Stachytarpheta cayennensis (L.C. Rich) Valh. J Ethnopharmacol 2006; 104: 225-233. (Pubitemid 43234108)
9. Efferth T et al. From traditional Chinese medicine to rational cancer therapy. Trends Mol Med 2007; 13: 353-361. (Pubitemid 47126989)
10. Lee KW et al. Acteoside inhibits human promyelocytic HL-60 leukemia cell proliferation via inducing cell cycle arret at G0/G1 phase and differentiation into monocyte. Carcinogenesis 2007; 28: 1928-1936.
11. Akbay P et al. In vitro immunomodulatory activity of verbascoside from Nepetya ucrainica L. Phytoter Res 2002; 16: 593-595.
12. Bilia AR et al. HPLC/DAD/ESI-MS analysis of the constituents of aqueous preparations of verbena and lemon verbena and evaluation of the antioxidant activity. J Pharm Biomed Anal 2008; 46: 463-470.
13. Lee JY et al. Inhibition of lipopolysaccharide-inducible nitric oxide synthase expression by acteoside trough blocking of AP-1 activation. J Ethnopharmacol 2005; 97: 561-566. (Pubitemid 40312335)
14. Avila Acevedo JG et al. Photoprotective activity of Buddleja scordioides. Fitoterapia 2005; 76: 301-309. (Pubitemid 40745204)
15. Backhouse N et al. Antinociceptive activity of Buddleja globosa (matico) in several models of pain. J Ethnopharmacol 2008; 119: 160-165.
16. Calvo MI. Anti-inflammatory and analgesic activity of the topical preparation of Verbena officinalis L. J Ethnopharmacol 2006; 107: 380-382. (Pubitemid 44344436)
17. Nakamura O et al. Acteoside as analgesic principle of Cedron (Lippia triphylla), a Peruvian medicinal plant. Chem Pharm Bull 1997; 45: 499-504.
18. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999; 353: 1959-1964.
19. Syndrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999; 83: 389-400.
20. Leighton GE et al. Intrathecal injection of a opioid agonist produces hyperalgesia in the guinea pig. Eur J Pharmacol 1988; 157: 241-242.
21. Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988; 33: 87-107.
22. Guingamp C et al. Mono-iodoacetate-induced experimental osteoarthritis: a dose-response study of loss of mobility, morphology, and biochemistry. Arthritis Rheum 1997; 40: 1670-1679. (Pubitemid 27426161)
23. Wiese C et al. Pharmacological and metabolic characterisation of the potent sigma(1) receptor ligand 1′-benzyl-3-methoxy-3Hspiro[[ 2]benzofuran-1,4′-piperidine]. J Pharm Pharmacol 2009; 61: 631-640.
24. Koltzenburg M. Painful neuropathies. Curr Opin Neurol 1998; 11: 515-521. (Pubitemid 28542986)